Long-term data from the OPRA trial show organ preservation at 5 years in about half of patients with stage II/III rectal adenocarcinoma who received total neoadjuvant therapy.
A marked reduction in colorectal cancer recurrence after surgery has led investigators to wonder whether some patients can skip intensive surveillance afterward.
After recovering from COVID-19, a woman was discovered unconscious at her workplace, triggering a series of events culminating in an unforeseen diagnosis.